secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001493152-24-043615
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics closes $1.275M private placement of common stock and warrants
--------------------------------------------------------------------------------

- Closed private placement on Nov 4, 2024; sold 1,948,295 shares of common stock.
- Issued series A warrants (18-month term) and series B warrants (5-year term), each exercisable at $0.64 per share.
- Gross proceeds of $1.275M; net proceeds to be used for working capital.
- Brookline Capital Markets acted as sole placement agent for the offering.
- Warrants exercisable only after stockholder approval date; no proceeds from warrants included in gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224043615/0001493152-24-043615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224043615/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer